Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis Strains
- 1 December 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (12) , 4274-4280
- https://doi.org/10.1128/aac.00740-08
Abstract
Candida dubliniensis , a yeast that is closely related to Candida albicans , can rapidly develop resistance to the commonly used antifungal agent fluconazole in vitro and in vivo during antimycotic therapy. Fluconazole resistance in C. dubliniensis is usually caused by constitutive overexpression of the MDR1 gene, which encodes a multidrug efflux pump of the major facilitator superfamily. The zinc cluster transcription factor Mrr1p has recently been shown to control MDR1 expression in C. albicans in response to inducing stimuli, and gain-of-function mutations in the MRR1 gene result in constitutive upregulation of the MDR1 efflux pump. We identified a gene with a high degree of similarity to C. albicans MRR1 (Ca MRR1 ) in the C. dubliniensis genome sequence. When C. dubliniensis MRR1 (Cd MRR1 ) was expressed in C. albicans mrr1 Δ mutants, it restored benomyl-inducible MDR1 expression, demonstrating that Cd MRR1 is the ortholog of Ca MRR1 . To investigate whether MDR1 overexpression in C. dubliniensis is caused by mutations in MRR1 , we sequenced the MRR1 alleles from a fluconazole-resistant, clinical C. dubliniensis isolate and a matched, fluconazole-susceptible isolate from the same patient as well as those from four in vitro-generated, fluconazole-resistant C. dubliniensis strains derived from two different C. dubliniensis isolates. We found that all five resistant strains contained single nucleotide substitutions or small in-frame deletions that resulted in amino acid changes in Mrr1p. Expression of these mutated alleles in C. albicans resulted in the constitutive activation of the MDR1 promoter and multidrug resistance. Therefore, mutations in MRR1 are the major cause of MDR1 upregulation in both C. albicans and C. dubliniensis , demonstrating that the transcription factor Mrr1p plays a central role in the development of drug resistance in these human fungal pathogens.Keywords
This publication has 49 references indexed in Scilit:
- Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strainsMolecular Microbiology, 2008
- Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicansAntimicrobial Agents and Chemotherapy, 2008
- The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicansPLoS Pathogens, 2007
- Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans IsolatesEukaryotic Cell, 2007
- Differential regulation of the transcriptional repressor NRG1 accounts for altered host‐cell interactions in Candida albicans and Candida dubliniensisMolecular Microbiology, 2007
- Proteomic Analysis Reveals a Metabolism Shift in a Laboratory Fluconazole-Resistant Candida albicans StrainJournal of Proteome Research, 2007
- Transcriptional Regulation of MDR1 , Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding SiteEukaryotic Cell, 2006
- A family of oligopeptide transporters is required for growth of Candida albicans on proteinsMolecular Microbiology, 2006
- Replacement of Candida albicans with C. dubliniensis in Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis Treated with FluconazoleJournal of Clinical Microbiology, 2002
- Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individualsMicrobiology, 1995